Literature DB >> 15599680

[Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial].

Dirk Lindner1, Joachim Lindner, Gunter Baumann, Horst Dawczynski, Karlheinz Bauch.   

Abstract

BACKGROUND AND
PURPOSE: Oxygen free radicals appear in the early phase of acute pancreatitis followed by an imbalance between the oxygen and anti-oxygen system. Sodium selenite may play an important role in the reduction of radicals in experimental pancreatitis. The aim of this study was to evaluate the effects of selenium in a clinical prospective trial. PATIENTS AND METHODS: 70 patients with acute pancreatitis were prospectively allocated to a selenium and a placebo group. Clinical and paraclinical parameters were investigated with a follow-up of 90 days after hospital stay.
RESULTS: The clinical course of the two treatment groups did not show statistically significant differences. Five patients in the selenium and three patients in the placebo group died. Depending on selenium therapy, antioxidant substances were presented in higher levels. All 17 clinical parameters showed no statistical significance.
CONCLUSION: Substitution of sodium selenite has no beneficial effect on the clinical outcome of patients with acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599680     DOI: 10.1007/s00063-004-1104-8

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  18 in total

1.  High-dose selenium substitution in sepsis: a prospective randomized clinical trial.

Authors:  Jiri Valenta; Helena Brodska; Tomas Drabek; Jan Hendl; Antonin Kazda
Journal:  Intensive Care Med       Date:  2011-02-24       Impact factor: 17.440

2.  Drug Therapy for Acute Pancreatitis.

Authors:  Yan Bi; Tegpal Atwal; Santhi Swaroop Vege
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

3.  Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis.

Authors:  Ajith K Siriwardena; James M Mason; Srinivasan Balachandra; Anil Bagul; Simon Galloway; Laura Formela; Jonathan G Hardman; Saurabh Jamdar
Journal:  Gut       Date:  2007-03-13       Impact factor: 23.059

4.  Role of Oxidative Stress in the Pathogenesis of Pancreatitis: Effect of Antioxidant Therapy.

Authors:  Lourdes Robles; Nosratola D Vaziri; Hirohito Ichii
Journal:  Pancreat Disord Ther       Date:  2013-04-01

5.  Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Ameliorates Acute Pancreatitis.

Authors:  Lourdes Robles; Nosratola D Vaziri; Shiri Li; Yuichi Masuda; Chie Takasu; Mizuki Takasu; Kelly Vo; Seyed H Farzaneh; Michael J Stamos; Hirohito Ichii
Journal:  Pancreas       Date:  2016 May-Jun       Impact factor: 3.327

6.  Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill?

Authors:  William Manzanares; Alberto Biestro; Federico Galusso; Maria H Torre; Nelly Mañay; Gustavo Pittini; Gianella Facchin; Gil Hardy
Journal:  Intensive Care Med       Date:  2008-11-26       Impact factor: 17.440

Review 7.  Experimental and clinical evidence of antioxidant therapy in acute pancreatitis.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

8.  Safety and efficacy of vitamin-based antioxidant therapy in patients with severe acute pancreatitis: a randomized controlled trial.

Authors:  Dipika Bansal; Ashish Bhalla; Deepak K Bhasin; Promila Pandhi; Navneet Sharma; Surinder Rana; Samir Malhotra
Journal:  Saudi J Gastroenterol       Date:  2011 May-Jun       Impact factor: 2.485

Review 9.  Selenium supplementation for critically ill adults.

Authors:  Mikkel Allingstrup; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2015-07-27

Review 10.  Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis.

Authors:  Ting-Shuo Huang; Yu-Chiau Shyu; Huang-Yang Chen; Li-Mei Lin; Chia-Ying Lo; Shin-Sheng Yuan; Pei-Jer Chen
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.